François Raffi

Research interests

Publications

• Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

  The Lancet HIV · 2018 · https://doi.org/10.1016/s2352-3018(18)30021-3

• Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial

  The Lancet Infectious Diseases · 2017 · https://doi.org/10.1016/s1473-3099(17)30725-9

• Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial

  The Lancet HIV · 2016 · https://doi.org/10.1016/s2352-3018(16)00024-2

• On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1506273

• Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

  The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)61170-3

• Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery

  Clinical Infectious Diseases · 2014 · https://doi.org/10.1093/cid/ciu038

• Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

  The Lancet Infectious Diseases · 2013 · https://doi.org/10.1016/s1473-3099(13)70257-3

• Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

  The Lancet · 2013 · https://doi.org/10.1016/s0140-6736(12)61853-4

• Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

  New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmoa0803154

• European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV‐infected adults

  HIV Medicine · 2008 · https://doi.org/10.1111/j.1468-1293.2007.00533.x

• Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

  The Lancet · 2004 · https://doi.org/10.1016/s0140-6736(04)15997-7

• Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen

  AIDS · 2002 · https://doi.org/10.1097/00002030-200201040-00004

• Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach

  Social Science & Medicine · 2002 · https://doi.org/10.1016/s0277-9536(01)00125-3

• Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART

  HIV Clinical Trials · 2001 · https://doi.org/10.1310/r8m7-eq0m-cnpw-39fc

• The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort

  JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · https://doi.org/10.1097/00042560-200111010-00005

• A Randomized Trial of Three Maintenance Regimens Given after Three Months of Induction Therapy with Zidovudine, Lamivudine, and Indinavir in Previously Untreated HIV-1–Infected Patients

  New England Journal of Medicine · 1998 · https://doi.org/10.1056/nejm199810293391802

• Opportunistic infections occurring during highly active antiretroviral treatment

  AIDS · 1998 · https://doi.org/10.1097/00002030-199814000-00013

• A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection

  New England Journal of Medicine · 1995 · https://doi.org/10.1056/nejm199508173330702

Current projects

No projects listed.